Advancing Public Health Research in Bangladesh
Closed Posted
- Opportunity number
- RFA-GH-24-033
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- Up to $6,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Other
Opportunity details come from Grants.gov. Updated .
About this opportunity
This cooperative agreement from the Centers for Disease Control and Prevention seeks applications for advancing public health research in Bangladesh. Up to $22 million in total funding over 5 years is available for high quality epidemiological, laboratory-based, and implementation science studies that characterize priority diseases, evaluate interventions and diagnostics, and measure impacts in Bangladesh. Eligible applicants are icddr,b, an international research institution based in Bangladesh with over 45 years of collaboration with CDC. Applications are due March 8, 2024, with project periods expected to run from September 2024 through September 2029. Funded research projects should focus on priority disease areas like acute febrile illness, encephalitic illness, antimicrobial resistance, and contribute to strengthening Bangladesh's surveillance and outbreak response capabilities.
The anticipated number of awards is one. Specifically, individual activities will determine burden, trends, etiology, and risk factors of priority diseases in Bangladesh, develop and evaluate interventions and diagnostics, evaluate the effectiveness of vaccinations to inform global policy, and strengthen the Government of Bangladesh's surveillance, laboratory and outbreak response capacity.
Synopsis
The purpose of this notice of funding opportunity is to further strengthen the ability of the Government of Bangladesh and other global partners to detect, prevent, and respond to disease threats through high quality public health research and surveillance activities. Specifically, the individual activities under this cooperative agreement will: a) determine burden, trends, etiology, and risk factors of priority diseases in Bangladesh, b) develop and evaluate interventions and diagnostics, c) evaluate the effectiveness of vaccinations to inform global policy, and d) strengthen the Government of Bangladesh's surveillance, laboratory and outbreak response capacity.
Files
| File | Type | Posted |
|---|---|---|
| Foa_Content_of_RFA-GH-24-033 Final.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity